Teomics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 2

Teomics General Information

Description

Owner and operator of a biotechnology company. The company focuses on research for tissue diagnosis and software development for pathology workflow.

Contact Information

Website
www.teomics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • 1800 Bering Drive
  • Suite 430
  • Houston, TX 77057
  • United States
+1 (844) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Teomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $50K Completed Startup
1. Accelerator/Incubator 12-Aug-2015 Completed Startup
To view Teomics’s complete valuation and funding history, request access »

Teomics Executive Team (2)

Name Title Board Seat Contact Info
Jason Eriksen Ph.D Co-Founder & Manager
You’re viewing 1 of 2 executive team members. Get the full list »

Teomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teomics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
RedLabs Accelerator Accelerator/Incubator 000 0000 000000 0
To view Teomics’s complete investors history, request access »